pharmaceutical intermediate suppliers are undergoing a fundamental transformation, evolving from traditional chemical manufacturers to indispensable innovation partners in the global healthcare ecosystem. This shift is driven by increasing complexity in drug development, pressure to accelerate timelines, and the growing sophistication of molecular structures in modern therapeutics. The future...